Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease
(NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important …

Background Combating viral hepatitis is part of the UN Sustainable Development Goals
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …

Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low
five-year survival rates leading to a substantial worldwide burden for healthcare systems …

Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …

Over 1.5 million preventable new hepatitis B infections continue to occur each year and
there are an estimated 296 million people living with chronic hepatitis B infection worldwide …

Hepatocellular carcinoma (HCC) is a global health challenge. Due to the high prevalence in
low-income countries, hepatitis B virus (HBV) and hepatitis C virus infections remain the …

Hepatocellular carcinoma (HCC) is a major public health problem worldwide for which the
incidence and mortality are similar, pointing to the lack of effective treatment options …

Today, hepatitis C virus infection affects up to 1.5 million people per year and is responsible
for 29 thousand deaths per year. In the 1970s, the clinical observation of unclear, transfusion …

Chronic Hepatitis B is a highly prevalent disease worldwide and is estimated to cause more
than 800000 annual deaths from complications such as cirrhosis and hepatocellular …